Preheparin serum lipoprotein lipase mass is negatively related to coronary atherosclerosis.
In preheparin serum, there exists lipoprotein lipase (LPL) mass with little activity. The clinical significance of this preheparin serum LPL mass (preheparin LPL mass) is unclear. We studied the levels of preheparin LPL mass in patients with coronary atherosclerosis, comparing the results with those in healthy men. We also evaluated the correlation between preheparin LPL mass and the severity of coronary atherosclerosis by comparing with other risk factors such as age, smoking, family history, hypertension, hyperuricemia, diabetes mellitus, total cholesterol, triglyceride, high density lipoprotein-cholesterol and body mass index. The subjects, 70 men presenting with symptoms of coronary artery disease, underwent coronary angiographic examination. Significant narrowness was defined as > or = 75%. Control group comprised 77 men who had annual health checks and showed no abnormal findings. Preheparin LPL mass in the stenosis group was lower than normal coronary group and also than the control group. Multivariate analysis showed that preheparin LPL mass had the highest t-value (-2.53) for the number of lesions among the risk factors listed above. These results suggest that low preheparin LPL mass may be deeply involved in the progression of coronary atherosclerosis.
Hitsumoto
T
T
Department of Clinical Medicine, Cardiovascular Center, Internal Medicine, Sakura Hospital, School of Medicine, TOHO University, Sakura-City, Chiba, Japan.
Ohsawa
H
H
Uchi
T
T
Noike
H
H
Kanai
M
M
Yoshinuma
M
M
Miyashita
Y
Y
Watanabe
H
H
Shirai
K
K
D000328:Adult; D000368:Aged; D015415:Biomarkers; D003324:Coronary Artery Disease / Q000097:blood* / Q000201:enzymology / Q000503:physiopathology; D006801:Humans; D008071:Lipoprotein Lipase / Q000097:blood*; D008297:Male; D008875:Middle Aged; D011379:Prognosis
D015415:Biomarkers; D008071:Lipoprotein Lipase